ScandiDos AB (OSTO:SDOS) Dividends Received


OSTO:SDOS ScandiDos AB OSTO:SDOS
47 GF Score
Price kr0.85
GF Value kr1.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is ScandiDos AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

OSTO:SDOS
47GF Score
ScandiDos AB OSTO:SDOS
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of kr0.85 is trading 25.4% below its estimated GF Value™ of kr1.14. GuruFocus considers ScandiDos AB to be Modestly Undervalued.

Key valuation signals for OSTO:SDOS:

  • Dividends Received:
  • GF Value™: kr1.14 vs. price of kr0.85 (25.4% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Address Uppsala Science Park, Uppsala, SWE, SE-751 83
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score

Get the complete analysis for OSTO:SDOS

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.85
Price
kr1.14
GF Value